Personalized cancer medicine

Personalized cancer medicine include studying a person's genetic makeup and tumor growth to prevent, diagnose and/or treat disease. Here is the latest research on personalized cancer medicine.

May 13, 2020

Molecular subtypes and precision treatment of triple-negative breast cancer

Annals of Translational Medicine
Shen ZhaoYi-Zhou Jiang
June 3, 2020

Moving Toward Precision Medicine in Psoriasis and Psoriatic Arthritis

The Journal of Rheumatology. Supplement
Christopher T RitchlinOliver FitzGerald
May 16, 2020

Engineered Niches to Analyze Mechanisms of Metastasis and Guide Precision Medicine

Cancer Research
Aaron H MorrisLonnie D Shea
May 27, 2020

A review of the phytochemistry and pharmacological activities of Ephedra herb

Chinese Journal of Natural Medicines
Shuang-Man MiaoMeng-Liang Wang
May 6, 2020
Comment / Editorial
Open Access

Tumor-agnostic precision oncology: striving to prioritize internationalization for the management of cancer patients

International Journal of Clinical Oncology
Yuko Kitagawa
May 15, 2020

Clinical Application of Computational Methods in Precision Oncology: A Review

JAMA Oncology
Orestis A PanagiotouChristopher R Cogle
May 1, 2020

Metatax: Metataxonomics with a Compi-Based Pipeline for Precision Medicine

Interdisciplinary Sciences, Computational Life Sciences
Osvaldo Graña-CastroDaniel Glez-Peña
May 23, 2020
Open Access

Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer

Advanced Science
Ahmed M E AbdallaGuang Yang
May 13, 2020
Open Access

The emerging roles of WBP2 oncogene in human cancers

Hossein TabatabaeianYoon Pin Lim
May 18, 2020

Information Sources Used by Oncologists to Understand Multi-marker Tumor Panel Tests for Cancer Patients

Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
Susan S BuckenmaierJanet S de Moor
May 18, 2020

Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide

International Journal of Radiation Oncology, Biology, Physics
Rifaquat RahmanBrian M Alexander
May 8, 2020

A novel cancer immunotherapy utilizing autologous tumour tissue

Vox Sanguinis
Haemin ParkAmanda Guth
May 29, 2020
Open Access

Patient-derived xenografts as compatible models for precision oncology

Laboratory animal research
Sung-Yup Cho
May 17, 2020
Open Access

Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer

Eleonora LaiMario Scartozzi
June 3, 2020

Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine

Mohammad Alinoor RahmanSaikat Nandi
May 6, 2020
Open Access

Harnessing the potential of CRISPR-based platforms to advance the field of hospital medicine

Expert Review of Anti-infective Therapy
Matthew W McCarthy
May 21, 2020

Correlated Mixed Membership Modeling of Somatic Mutations

arXiv Quantitative Biology
Rahul Mehta, Muge Karaman

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2020 Meta ULC. All rights reserved